牙周病市場－全球產業規模、佔有率、趨勢、機會、預測：按治療方法、最終用戶、地區和競爭對手分類，2021-2031年

全球牙周病治療市場預計將從 2025 年的 21.2 億美元成長到 2031 年的 31.9 億美元，複合年成長率為 7.05%。

該行業細分領域涵蓋用於預防、診斷和治療牙周疾病（如牙齦炎和牙周炎）的專業牙科治療產品和醫療設備，包括局部和全身抗菌劑、手術器械和骨移植材料。市場成長的主要促進因素是全球人口老化，老年人更容易出現牙周組織退化，以及臨床上對口腔健康與糖尿病等全身性疾病之間雙向連結的認知不斷提高。這些因素正在催生對超越純粹美學牙科趨勢的有效醫療保健管理解決方案的持續需求。

同時，由於報銷政策普遍存在缺陷，市場面臨許多障礙。這導致許多地區的患者自付費用高昂，治療順從性下降。這種經濟障礙限制了患者獲得先進治療方法和必要的長期維護通訊協定。根據世界牙科聯盟（FDI）2025年的數據，預計全球將有超過10億人患有嚴重的牙周疾病，凸顯了這種疾病負擔與必要治療的經濟可及性之間存在的巨大差距。

市場促進因素

全球牙周疾病盛行率的不斷上升是推動市場擴張的主要動力，持續的治療性介入已成為基本要求。隨著牙齦炎發展為重度牙周炎，工作量也隨之增加，需要更多的診斷篩檢、潔治和藥物治療。這種基於數量的需求在口腔衛生教育有限的開發中國家尤其突出，但在人口老化的已開發國家，這仍然是一個持續存在的挑戰。美國國立衛生研究院 (NIH) 在 2025 年 7 月的一項研究估計，每年新增病例約為 8,960 萬例，凸顯了需要治療的新患者數量持續成長。

此外，人們日益認知到口腔健康與慢性疾病之間的系統性聯繫，這正在改變治療通訊協定和患者轉診網路。臨床醫生正轉向整體模式，將牙周管理納入糖尿病和心血管疾病等全身性疾病的治療計劃中，從而提升牙周管理的地位，使其從選擇性的口腔衛生管理提升為必要的醫療保健管理。 2024年11月，歐洲牙周病學會報告稱，一項研究發現，糖尿病患者患重度牙周病的可能性是非糖尿病患者的三倍。這項轉變也得到了經濟趨勢的支持，美國牙醫協會預測，2025年消費者牙科支出將成長3%，這顯示人們對口腔保健的持續投入。

市場挑戰

全球牙周病市場面臨的一大障礙是普遍缺乏完善的報銷政策，這對患者和牙科服務提供者都造成了巨大的經濟負擔。牙周病治療的保險覆蓋範圍有限，迫使患者承擔高昂的自付費用，常常導致必要的治療被延誤或拒絕。這種經濟限制直接抑制了對先進牙科治療方法、手術器械和昂貴再生材料的需求，因為患者傾向於選擇價格較低或創傷較小的替代方案。

此外，當報銷率不足以覆蓋營運成本時，牙科診所往往會避免投資高品質的牙周治療技術，導致市場停滯不前，儘管臨床需求不斷成長。根據美國牙科協會 (ADA) 預測，到 2025 年，約 58% 的牙科專業人士會將低報銷率和理賠被拒絕視為其診所永續性和提供最佳護理的主要障礙。這種經濟差距有效地抑制了牙周相關產品的商業性化應用，並限制了整個產業的擴張。

市場趨勢

將人工智慧 (AI) 應用於預測性診斷，從根本上重塑了牙周病治療的基礎，將臨床工作流程從主觀評估轉變為客觀、數據驅動的疾病管理。如今，AI 演算法能夠自動量化骨骼水平測量值，並以比傳統人工方法更高的精度識別早期放射學骨吸收，從而提高診斷準確性和患者信心。這項技術進步直接促進了收入成長，並透過清晰地向無症狀牙周病患者展示治療必要性，有效彌合了溝通鴻溝。根據 2025 年 7 月《富比士》雜誌的一篇報導（引用 Overjet 的一項調查），72% 的患者表示，如果向他們展示 AI 生成的觀察，他們會更容易接受牙醫的診斷和治療方案，這凸顯了該技術在提案治療方法轉化為實際治療方面發揮的關鍵作用。

同時，再生組織工程和生物製藥的進步正在重新定義治療的可能性，使牙周支持組織的修復不再僅限於阻止疾病進展。臨床醫生擴大使用先進的生物材料，例如生長因子增強型骨移植材料和屏障膜，以促進受損牙齒和植入周圍牙周組織的真正再生。這種向生物保存的轉變支撐著主要產業參與者強勁的商業性表現，並在普遍的經濟逆風中推動了對高品質再生醫學產品組合的需求。例如，士卓曼集團在2025年2月報告稱，其年銷售額將達25億瑞士法郎。這一數字主要得益於該公司高品質植入和生物材料解決方案在全球主要市場的持續應用。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球牙周病市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 治療方法（非手術治療（局部抗生素、全身性抗生素、雷射治療）、手術器械（骨植入、骨移植））
  • 依最終使用者（醫院/診所、門診手術中心、其他）分類
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美牙周病市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲牙周病市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區牙周病市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲牙周病市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲牙周病市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章：全球牙周病市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Medtronic PLC
• Straumann AG
• The 3M Company
• Bausch Health Companies Inc.
• Dentsply Sirona Group
• Pfizer Inc.
• Novartis AG
• Dentsply Sirona Inc.
• Danaher Corporation
• GC Corporation

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Periodontal Market is projected to expand from a valuation of USD 2.12 Billion in 2025 to USD 3.19 Billion by 2031, reflecting a CAGR of 7.05%. This industry segment encompasses a specialized array of dental therapeutics and devices aimed at preventing, diagnosing, and treating gum diseases such as gingivitis and periodontitis, including local and systemic antimicrobials, surgical instrumentation, and regenerative bone grafts. The market's growth is fundamentally anchored by an aging global population, which is inherently more prone to periodontal degeneration, alongside rising clinical acknowledgment of the bi-directional link between oral health and systemic issues like diabetes. These drivers generate a lasting demand for effective medical management solutions, distinguishing them from purely cosmetic dental trends.

Conversely, the market encounters significant hurdles due to the widespread insufficiency of reimbursement policies, which result in high out-of-pocket expenses and reduce patient adherence in many areas. This financial obstacle restricts access to advanced therapies and necessary long-term maintenance protocols. Data from the FDI World Dental Federation in 2025 estimated that severe periodontal diseases affected over one billion cases globally, highlighting a profound disparity between the substantial disease burden and the economic accessibility of required treatments.

Market Driver

The escalating global prevalence of periodontal diseases serves as the primary engine for market expansion, establishing a fundamental requirement for continuous therapeutic intervention. As gum conditions advance from gingivitis to severe periodontitis, the clinical workload necessitates a higher volume of diagnostic screenings, scaling procedures, and pharmacological treatments. This volume-based demand is particularly intense in developing nations where oral hygiene education is limited, yet it remains a persistent issue in developed countries due to aging demographics. According to a July 2025 study by the National Institutes of Health on the global burden of periodontal diseases, estimates indicated approximately 89.6 million incident cases in a single year, underscoring the constant influx of new patients requiring care.

Additionally, growing awareness regarding the systemic connection between oral health and chronic diseases is transforming treatment protocols and patient referral networks. Clinicians are increasingly moving toward a holistic model where periodontal management is integrated into care plans for systemic conditions such as diabetes mellitus and cardiovascular disease, elevating it from elective hygiene to essential medical management. The European Federation of Periodontology reported in November 2024 that studies show diabetics face a threefold higher risk of severe gum disease compared to non-diabetics. This shift is supported by economic trends; the American Dental Association recorded a 3% increase in consumer dental spending in 2025, signaling a sustained financial commitment to oral healthcare.

Market Challenge

The widespread absence of adequate reimbursement policies acts as a major impediment to the Global Periodontal Market, creating a significant financial barrier for both patients and dental providers. Limited insurance coverage for periodontal procedures compels patients to shoulder high out-of-pocket costs, often resulting in the delay or refusal of essential treatments. This economic constraint directly dampens the demand for advanced dental therapeutics, surgical instrumentation, and expensive regenerative materials, as patients frequently choose cheaper or less invasive alternatives.

Furthermore, dental practices are discouraged from investing in premium periodontal technologies when compensation rates fail to cover operational costs, leading to market stagnation despite the rising clinical need. According to the American Dental Association, in 2025, approximately 58 percent of dental practitioners identified low insurance reimbursement rates and claim denials as a primary challenge hindering their ability to maintain practice viability and deliver optimal care. This financial disconnect effectively suppresses the commercial adoption of periodontal products and restricts the broader expansion of the sector.

Market Trends

The integration of Artificial Intelligence into predictive diagnostics is fundamentally reshaping the periodontal landscape by shifting clinical workflows from subjective assessment to objective, data-driven disease management. AI algorithms now automatically quantify bone level measurements and identify early-stage radiographic bone loss with a precision that exceeds traditional manual methods, thereby enhancing diagnostic accuracy and patient trust. This technological evolution directly benefits practice revenue cycles by validating treatment necessity to patients who often struggle to visualize asymptomatic gum disease, effectively bridging the communication gap. A July 2025 Forbes article citing an Overjet survey noted that 72% of patients would be more likely to accept a dentist's diagnosis and treatment plan if presented with AI-generated findings, highlighting the technology's critical role in converting proposed therapies into active cases.

Simultaneously, advancements in Regenerative Tissue Engineering and Biologics are redefining therapeutic possibilities by enabling the restoration of lost periodontal support structures rather than merely arresting disease progression. Clinicians are increasingly utilizing advanced biomaterials, such as growth-factor-enhanced bone grafts and barrier membranes, to facilitate true periodontal regeneration around compromised teeth and implants. This shift toward biological preservation is sustaining robust commercial performance for major industry players, driving demand for premium regenerative portfolios despite broader economic headwinds. For instance, the Straumann Group reported in February 2025 that their full-year revenue reached CHF 2.5 billion, a figure significantly bolstered by the continued adoption of their premium implant and biomaterial solutions in key global markets.

Key Market Players

• Medtronic PLC
• Straumann AG
• The 3M Company
• Bausch Health Companies Inc.
• Dentsply Sirona Group
• Pfizer Inc.
• Novartis AG
• Dentsply Sirona Inc.
• Danaher Corporation
• GC Corporation

Report Scope

In this report, the Global Periodontal Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Periodontal Market, By Therapy

• Non-surgical Treatment (Local Antibiotics, Systemic Antibiotics, Laser Treatment)
• Surgical Devices (Bone Implants, Bone Grafting)

Periodontal Market, By End User

• Hospitals & Clinics
• Ambulatory Surgical Centers
• Others

Periodontal Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Periodontal Market.

Available Customizations:

Global Periodontal Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Periodontal Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Therapy (Non-surgical Treatment (Local Antibiotics, Systemic Antibiotics, Laser Treatment), Surgical Devices (Bone Implants, Bone Grafting))
  • 5.2.2. By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2025)
• 5.3. Market Map

6. North America Periodontal Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Therapy
  • 6.2.2. By End User
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Periodontal Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Therapy
      • 6.3.1.2.2. By End User
  • 6.3.2. Canada Periodontal Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Therapy
      • 6.3.2.2.2. By End User
  • 6.3.3. Mexico Periodontal Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Therapy
      • 6.3.3.2.2. By End User

7. Europe Periodontal Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Therapy
  • 7.2.2. By End User
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Periodontal Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Therapy
      • 7.3.1.2.2. By End User
  • 7.3.2. France Periodontal Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Therapy
      • 7.3.2.2.2. By End User
  • 7.3.3. United Kingdom Periodontal Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Therapy
      • 7.3.3.2.2. By End User
  • 7.3.4. Italy Periodontal Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Therapy
      • 7.3.4.2.2. By End User
  • 7.3.5. Spain Periodontal Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Therapy
      • 7.3.5.2.2. By End User

8. Asia Pacific Periodontal Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Therapy
  • 8.2.2. By End User
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Periodontal Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Therapy
      • 8.3.1.2.2. By End User
  • 8.3.2. India Periodontal Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Therapy
      • 8.3.2.2.2. By End User
  • 8.3.3. Japan Periodontal Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Therapy
      • 8.3.3.2.2. By End User
  • 8.3.4. South Korea Periodontal Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Therapy
      • 8.3.4.2.2. By End User
  • 8.3.5. Australia Periodontal Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Therapy
      • 8.3.5.2.2. By End User

9. Middle East & Africa Periodontal Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Therapy
  • 9.2.2. By End User
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Periodontal Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Therapy
      • 9.3.1.2.2. By End User
  • 9.3.2. UAE Periodontal Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Therapy
      • 9.3.2.2.2. By End User
  • 9.3.3. South Africa Periodontal Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Therapy
      • 9.3.3.2.2. By End User

10. South America Periodontal Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Therapy
  • 10.2.2. By End User
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Periodontal Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Therapy
      • 10.3.1.2.2. By End User
  • 10.3.2. Colombia Periodontal Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Therapy
      • 10.3.2.2.2. By End User
  • 10.3.3. Argentina Periodontal Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Therapy
      • 10.3.3.2.2. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Periodontal Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Medtronic PLC
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Straumann AG
• 15.3. The 3M Company
• 15.4. Bausch Health Companies Inc.
• 15.5. Dentsply Sirona Group
• 15.6. Pfizer Inc.
• 15.7. Novartis AG
• 15.8. Dentsply Sirona Inc.
• 15.9. Danaher Corporation
• 15.10. GC Corporation

16. Strategic Recommendations

17. About Us & Disclaimer